Featured Blog Posts – July 2010 Archive (3)


Staff
A Bedtime Story

Who gets the award for finding the treatment or cure? I received this question over and over and yesterday again, in an email from a parent. She provided a list of each organization and what projects or companies they have supported. In my head, I wanted to say all of us, some of us, what does it matter as long as the drug is developed, the project funded. Her real question was –if I raise money for you, will you get ‘the cure’ for my son? My first thought was to say – ‘cures’ do not come from… Continue

Added by Pat Furlong on July 27, 2010 at 1:08pm — 2 Comments


Staff
Conference 2010

I’m not going to recap the 30+ hours of presentations from this year’s Conference. We will soon post many of the presentations and Sharon will blog about various presentations and projects over the next weeks and months. I wanted to tell you a bit about what took place this year and look forward, to share some thoughts about next year… Already you ask? We spend a lot of time thinking about the Conference, trying to improve it each year, trying to make sure we provide comprehensive information… Continue

Added by Pat Furlong on July 7, 2010 at 4:29pm — 6 Comments

Rock, meet Hard Place

The news that GSK is not pursuing a phase III study for skipping exon 51 here in the US has certainly come as a blow. It seems that the FDA would like to see longer term toxicology data before approving the 48 week human study. Meanwhile, almost every European family with DMD will have access to the phase III study. It seems obvious that the FDA is being blindly obstructionist and GSK is showing its true stripes as money-sucking big pharma company that is going to choose the path of least…

Continue

Added by Sharon Hesterlee on July 6, 2010 at 4:00pm — 24 Comments

Featured Monthly Archives

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2018   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service